Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX
· Real-Time Price · USD
3.06
-0.16 (-4.97%)
At close: Aug 19, 2025, 11:20 AM
Evaxion Biotech A/S Revenue
Evaxion Biotech A/S reported an annual revenue of $3.34M, reflecting a 4480.82% growth. For the quarter ending March 31, 2025, Evaxion Biotech A/S generated $0 in revenue.
Revenue (ttm)
3.34M
Revenue Growth
4480.82%
Price / Sales Ratio
1.36
Revenue / Employee
72.7K
Employees
46
Market Cap
19.36M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 3.34M | +4480.82% |
| Dec 31, 2023 | 73K | +Infinity% |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | n/a |